Circuit Training With and Without Upper and Lower Limb Resistance Training in Post-CABG Patients
Effects of Circuit Training With and Without Upper and Lower Limb Resistance Training on Paroxysmal Nocturnal Dyspnea, Functional Capacity and Endurance in Post-CABG Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
This study aims to evaluate the contrasting effects of circuit training with and without upper and lower limb resistance training on paroxysmal nocturnal dyspnea, functional capacity and endurance on post-CABG patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2025
CompletedFirst Submitted
Initial submission to the registry
March 16, 2026
CompletedFirst Posted
Study publicly available on registry
March 20, 2026
CompletedMarch 20, 2026
March 1, 2026
2 months
March 16, 2026
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Modified Medical Research Council (mMRC)
The mMRC Dyspnea Scale is a validated tool to assess the severity of dyspnea among the patients with pulmonary complications. This scale was utilized to quantify the symptoms of paroxysmal nocturnal dyspnea among the participants in the study, offering an insight to the effectiveness of exercise interventions on the respiratory symptoms
First day
1-Repetition Maximum (1-RM)
1-RM is a useful tool in the studies in the studies evaluating the effectiveness of strength training such as those addressing upper and lower limb resistance training. This test specifies the maximum weight that a subject can lift in a single repetition, providing a precise, quantitative baseline evaluation of dynamic strength. It can be used as a solid baseline for tracking and comparing strength changes during intervention. Thus, 1-RM is a practical and objective tool in rehabilitation research. It allows the researchers to analyze the effectiveness of certain treatments and monitor functional changes over the course of treatment or regimen.
First day
Modified Borg Scale (BORG CR-10):
Modified Borg Dyspnea Scale is a highly validated subjective tool, to assess rate of perceived exertion during exercise to monitor exercise intensity and tailor to individual patient in cardiac rehabilitation settings. It is safe and cost-effective. It has a rating of 0-10 with zero representing (no breathlessness) and 10 (maximal exertion). It is a subjective measure of how hard the body is pushing against exertion during exercise. Specially designed for the assessment of cardiac endurance
First day
6-Minute Walk Test 6-MWT:
It is a reliable tool for assessing functional capacity among the patient population that present with underlying cardiovascular and pulmonary conditions. We used this tool in the assessment of functional capacity among the patients that participated in the study. This test specifically measures the distance covered in 6 minutes. In this test the participant walks along a flat straight pathway (usually 30-meter indoor corridors) in six minutes at their own pace. The maximum distance covered in 6 minutes documented the functional capacity among the participants under study.
First day
Incremental Shuttle Walk Test (ISWT)
Incremental Shuttle Walk Test (ISWT) is a highly reliable and valid tool for the assessment of cardiac endurance as a distinct outcome separately from overall functional capacity. It measures cardiac endurance under progressively increasing workloads within the safe limits. We used this tool to assess the cardiopulmonary endurance and baseline functional status in CABG population and to measure the improvements post-intervention outcomes. The test is safe, cost-effective and convenient to implement in all the clinical settings requiring little equipment and simultaneously assesses physiological responses such as heart-rate HR, oxygen saturation SPO2, and blood pressure in accordance with the subjective effort.
First day
Study Arms (2)
Group A: Circuit Training with upper and lower limb Resistance Training
EXPERIMENTALA series of exercises in a circuit format with Resistance Training: for upper and lower limbs (30-40% of 1-RM)
Group B: Circuit Training only
EXPERIMENTALExercises in circuit format (30-40 minutes)
Interventions
A series of exercises in a circuit format, with 1 minute of exercise followed by 30 seconds of rest. The circuit was repeated 2-3 times, with a 2-minute break between circuits along with upper and lower limb Resistance exercises (30-40% of 1-RM) using weights and therapeutic bands
A series of exercises in a circuit format, with 1 minute of exercise followed by 30 seconds of rest. The circuit was repeated 2-3 times, with a 2-minute break between circuits.
Eligibility Criteria
You may qualify if:
- Adult CABG surgery candidates aged between 35 and 65 years who underwent uncomplicated CABG surgery within past 3-6 months.
- No history of pre-existing pulmonary disease.
- Clinically stable cardiac status and approval for participation in phase-II cardiac rehabilitation from the cardiac surgeon.
- Patients that presented with the symptoms of mild to moderate levels of paroxysmal nocturnal dyspnea (PND). (38)
- Willingness and availability to participate in the phase-II cardiac rehabilitation program for the study duration.
- Physical ability to perform both upper and lower limb strength training exercise.
- Absence of pre-existing severe orthopedic limitations that could interfere with the exercise performance.
You may not qualify if:
- Uncontrolled hypertension, cardiac arrhythmias or any unstable cardiovascular complication that was an absolute contraindication to participate in clinical exercise program.
- Severe pre-existing pulmonary conditions such as COPD or Asthma that could interfere with exercise capacity.
- Severe orthopedic limitations such as arthritis, recent fractures and sternal site infections post-surgery.
- Neurological complications, including stroke, severe neuropathy, balance and coordination abnormalities that could impede physical performance.
- Cognitive impairments that may possibly affect the ability to understand and follow the exercise protocols.
- Participation in some other structured rehabilitation program within the past month.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Punjab Institute of Cardiology
Lahore, Punjab Province, 54000, Pakistan
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Qurat ul Ain, MS
Riphah International University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2026
First Posted
March 20, 2026
Study Start
July 5, 2025
Primary Completion
August 20, 2025
Study Completion
December 20, 2025
Last Updated
March 20, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share